Evidence map›Paper›PMID 28684418›Full record

ArticleThe Journal of biological chemistry2017

The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis.

Carlos Vaamonde-Garcia, Alice Courties, Audrey Pigenet, Marie-Charlotte Laiguillon, Alain Sautet, Xavier Houard, Saadia Kerdine-Römer, Rosa Meijide, Francis Berenbaum, Jérémie Sellam

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Reduced Levels of HAntioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Carlos Vaamonde-GarciaFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Alice CourtiesFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Audrey PigenetFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Marie-Charlotte LaiguillonFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Alain SautetFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Xavier HouardFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Saadia Kerdine-RömerINSERM UMR 996, University of Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France.
Rosa MeijideTissue Engineering and Cellular Therapy Group, Department of Medicine, University of A Coruña, 15006 A Coruña, Spain.
Francis BerenbaumFrom the Sorbonne University, UPMC University of Paris 06, Paris, France, francis.berenbaum@aphp.fr.
Jérémie SellamFrom the Sorbonne University, UPMC University of Paris 06, Paris, France.
Hôpital Saint-Antoine · FRSorbonne Université · FRUniversité Paris Cité · FRCentre de Recherche Saint-Antoine · FRInserm · FRUniversidade da Coruña · ESUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological findings support the hypothesis that type 2 diabetes mellitus (T2DM) is a risk factor for osteoarthritis (OA). Moreover, OA cartilage from patients with T2DM exhibits a greater response to inflammatory stress, but the molecular mechanism is unclear. To investigate whether the antioxidant defense system participates in this response, we examined here the expression of nuclear factor-erythroid 2-related factor (Nrf-2), a master antioxidant transcription factor, and of heme oxygenase-1 (HO-1), one of its main target genes, in OA cartilage from T2DM and non-T2DM patients as well as in murine chondrocytes exposed to high glucose (HG).

Indexed as

Gene Expression RegulationOxidative StressAgedAnimalsAnimals, NewbornCartilage, ArticularCells, CulturedChondrocytesDiabetes Mellitus, Type 2FemaleHeme Oxygenase-1HumansMaleMembrane ProteinsMice, Inbred C57BLMice, KnockoutHeme Oxygenase-1HMOX1 protein, humanHmox1 protein, mouseMembrane ProteinsNFE2L2 protein, humanNfe2l2 protein, mouseNF-E2-Related Factor 2diabetesheme oxygenaseinflammationNuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2)osteoarthritis

Identifiers

PMID28684418
PMCPMC5582843
OpenAlexW2726420849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.